| |
| |
|
| Insider
Information: |
Johnson Paul H |
| Relationship: |
Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
103,095 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,095 |
|
|
| Total
Value |
$15 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adhera Therapeutics, Inc |
ATRX |
Sr VP of R&D, CSO |
2007-10-05 |
29,301 |
2005-01-21 |
0 |
Premium* |
|
|
Phaserx, Inc. |
PZRX |
Director |
2016-05-17 |
73,794 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PZRX |
Phaserx, Inc. |
Director |
– • – |
2016-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
73,794 |
|
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-10-05 |
4 |
D |
$15.23 |
$10,052 |
D/D |
(660) |
29,301 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-09-06 |
4 |
S |
$14.30 |
$674,969 |
D/D |
(47,200) |
29,961 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-09-06 |
4 |
OE |
$9.36 |
$539,225 |
D/D |
57,316 |
32,161 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-23 |
4 |
S |
$14.30 |
$15,734 |
D/D |
(1,100) |
19,845 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-23 |
4 |
OE |
$9.36 |
$12,533 |
D/D |
1,339 |
20,945 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-22 |
4 |
S |
$14.30 |
$293,979 |
D/D |
(20,558) |
19,606 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-22 |
4 |
OE |
$9.36 |
$262,623 |
D/D |
28,058 |
40,164 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-21 |
4 |
S |
$14.50 |
$56,550 |
D/D |
(3,900) |
12,106 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-08-21 |
4 |
OE |
$9.36 |
$55,729 |
D/D |
5,954 |
16,006 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2007-01-22 |
4 |
D |
$13.31 |
$4,685 |
D/D |
(352) |
10,052 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2006-10-05 |
4 |
S |
$15.54 |
$10,272 |
D/D |
(661) |
10,404 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
officerTitle |
• – – |
2006-01-23 |
4 |
D |
$14.40 |
$6,264 |
D/D |
(435) |
11,065 |
|
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Sr VP of R&D, CSO |
• – – |
2005-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
11,500 |
|
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Senior Vice President of Resea |
• – – |
2005-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
